会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 43. 发明授权
    • Microfluidic device, system, and method for controlled encapsulation of particles or particle clusters
    • 微流体装置,系统和用于颗粒或颗粒簇的可控包封的方法
    • US09012203B2
    • 2015-04-21
    • US12465112
    • 2009-05-13
    • Florence RiveraJean BerthierSophie Le Vot
    • Florence RiveraJean BerthierSophie Le Vot
    • C12M3/00C12N11/04
    • C12N11/04
    • A microfluidic device for controlled encapsulation of particles of sub-millimetric dimensions, or clusters of such particles, the device comprising: a first duct for delivering a first liquid phase containing particles for encapsulating in suspension; a second duct for conveying a flow of a second liquid phase that is immiscible with said first liquid phase; the first duct opening out into the second duct and forming a fluidic junction therewith; at least one microfluidic duct for discharging the first liquid phase flowing in said first duct and provided with a mouth located upstream from said junction and liable to be obstructed, at least in part, by a particle in suspension, thereby causing pressure to rise in the first duct. The invention also provides a microfluidic system including such a device, and a method of encapsulation based on using such a device.
    • 一种微流体装置,其用于控制​​密封亚毫米级的颗粒或这种颗粒的簇,所述装置包括:用于输送含有颗粒的第一液相以封装在悬浮液中的第一管道; 用于输送与所述第一液相不混溶的第二液相的流的第二管道; 第一管道打开进入第二管道并与其形成流体连接点; 至少一个微流体管道,用于排出在所述第一管道中流动的第一液相,并且设置有位于所述接合部上游的口部,并且至少部分地由悬浮物中的颗粒阻塞,从而在 第一管。 本发明还提供了一种包括这种装置的微流体系统,以及基于使用这种装置的封装方法。
    • 46. 发明授权
    • Protein complex having activity catalyzing asymmetric oxidation reaction and process for producing the same
    • 具有催化不对称氧化反应的活性的蛋白质复合物及其制备方法
    • US08852904B2
    • 2014-10-07
    • US13321520
    • 2010-05-20
    • Hiroyuki Nagaoka
    • Hiroyuki Nagaoka
    • C12P7/02A61L33/00C12P7/26C12N11/04C12P41/00C12N9/96C12N9/02
    • C12P7/02C12N9/0004C12N9/96C12N11/04C12P7/26C12P41/002Y02P20/52Y02P20/588
    • A process for producing a cross-linked crystallized protein complex, which comprises: a first step of concentrating a crude protein derived from an animal or plant; a second step of encapsulating the protein in a gel, to thereby allow the protein to undergo air oxidation, and then extracting a protein complex from the gel; a third step of allowing the extracted protein complex to undergo crystallization and precipitation; and a fourth step of cross-linking the precipitated protein complex. Alternatively, by use of a fifth step of drying (FD) the obtained crosslinked crystallized protein complex, to thereby form a powder. As a result, there is provided an enzyme which is stable at room temperature storage, and has an activity in catalyzing an asymmetric oxidation reaction. That is, there is provided a useful material which enables an efficient enzyme-mimetic reaction under a mild condition.
    • 一种生产交联结晶蛋白复合物的方法,其包括:浓缩源自动物或植物的粗蛋白质的第一步骤; 将蛋白质包封在凝胶中的第二步骤,从而使蛋白质经历空气氧化,然后从凝胶中提取蛋白质复合物; 第三步,使提取的蛋白质复合物进行结晶析出; 以及交联沉淀的蛋白质复合物的第四步骤。 或者,通过使用所获得的交联结晶蛋白复合物的干燥(FD)的第五步骤,从而形成粉末。 结果,提供了一种在室温下稳定的酶,并且具有催化不对称氧化反应的活性。 也就是说,提供了在温和条件下能够进行有效的酶模拟反应的有用材料。